D. Newby

First name

D.

Last name

Newby

Barclay, N. L., Burkard, T., Burn, E., Delmestri, A., Dominguez, M., Golozar, A., et al. (2024). The Impact of the COVID-19 Pandemic on Incidence and Short-Term Survival for Common Solid Tumours in the United Kingdom: A Cohort Analysis. Clin Epidemiol, 16, 417-429. http://doi.org/10.2147/clep.s463160

View

Barclay, N. L., Català, M., Jödicke, A. M., Prieto-Alhambra, D., Newby, D., Delmestri, A., et al. (2024). Collateral effects of the COVID-19 pandemic on endocrine treatments for breast and prostate cancer in the UK: a cohort study. Ther Adv Med Oncol, 16, 17588359241253115. http://doi.org/10.1177/17588359241253115

View

Reyes, C., Newby, D., Raventós, B., Verhamme, K., Mosseveld, M., Prieto-Alhambra, D., et al. (2024). Trends of use and characterisation of anti-dementia drugs users: a large multinational-network population-based study. Age Ageing, 53. http://doi.org/10.1093/ageing/afae106

View

Raventós, B., Català, M., Du, M., Guo, Y., Black, A., Inberg, G., et al. (2023). IncidencePrevalence: An R package to calculate population-level incidence rates and prevalence using the OMOP common data model. Pharmacoepidemiol Drug Saf. http://doi.org/10.1002/pds.5717

View

Lane, J. C. E., Weaver, J., Kostka, K., Duarte-Salles, T., Abrahao, M. T. F., Alghoul, H., et al. (2020). Risk of depression, suicide and psychosis with hydroxychloroquine treatment for rheumatoid arthritis: a multinational network cohort study. Rheumatology (Oxford). http://doi.org/10.1093/rheumatology/keaa771

View

Lane, J. C. E., Weaver, J., Kostka, K., Duarte-Salles, T., Abrahao, M. T. F., Alghoul, H., et al. (2020). Risk of hydroxychloroquine alone and in combination with azithromycin in the treatment of rheumatoid arthritis: a multinational, retrospective study. Lancet Rheumatol. http://doi.org/10.1016/s2665-9913(20)30276-9

View